Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00753
|
|||||
| Drug Name |
Rofecoxib
|
|||||
| Synonyms |
3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one; 3-Phenyl-4-(4-(methylsulfonyl)phenyl))-2(5H)-furanone; 3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone; 4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone; 4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one; 4-(p-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone; 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone; 4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one; Cahill May Roberts brand of rofecoxib; Ceeoxx (TN); Ceoxx; Ceoxx (TN); KS-1107; MK 0966; MK 0996; MK 966; MK-0966; MK-966; MK0966; MSD brand of rofecoxib; Merck Frosst brandof rofecoxib; Merck Sharp & Dhome brand of rofecoxib; Merck brand of rofecoxib; Refecoxib; Rofecoxib (JAN/USAN/INN); Vioxx; Vioxx (TN); Vioxx (trademark); Vioxx Dolor
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antiinflammatory Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H14O4S
|
|||||
| Canonical SMILES |
CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
|
|||||
| InChI |
InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3
|
|||||
| InChIKey |
RZJQGNCSTQAWON-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 162011-90-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 314.4 | Topological Polar Surface Area | 68.8 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
2.3
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:8887
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.